|
ATG4C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8961499037573E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.76996261670138E-15 |
| Normal-vs-Stage2 |
3.60469999960422E-07 |
| Normal-vs-Stage3 |
1.64300000049522E-07 |
| Normal-vs-Stage4 |
1.04820000002004E-06 |
| Stage1-vs-Stage2 |
2.009200E-01 |
| Stage1-vs-Stage3 |
5.932600E-01 |
| Stage1-vs-Stage4 |
8.619400E-01 |
| Stage2-vs-Stage3 |
5.048000E-01 |
| Stage2-vs-Stage4 |
4.441000E-01 |
| Stage3-vs-Stage4 |
8.754400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67310609811011E-12 |
| Normal-vs-AfricanAmerican |
8.15249978636245E-10 |
| Normal-vs-Asian |
3.447000E-01 |
| Caucasian-vs-AfricanAmerican |
2.471400E-01 |
| Caucasian-vs-Asian |
3.858600E-01 |
| AfricanAmerican-vs-Asian |
3.065600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87627691161651E-14 |
| Normal-vs-Female |
6.83709999727E-09 |
| Male-vs-Female |
5.581600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.36069991017041E-10 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.02700070669925E-11 |
| Normal-vs-Extreme_Obese |
2.057200E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.741200E-01 |
| Normal_Weight-vs-Obese |
7.977600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.787800E-01 |
| Extreme_Weight-vs-Obese |
1.386410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.923200E-01 |
| Obese-vs-Extreme_Obese |
7.427200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.2752999999941E-06 |
| Normal-vs-Age(41-60Yrs) |
1.00950359183116E-11 |
| Normal-vs-Age(61-80Yrs) |
8.43769498715119E-15 |
| Normal-vs-Age(81-100Yrs) |
1.64060000029664E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.635800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.828400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.100200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.039600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.698400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.424800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
4.5196002496084E-10 |
| Normal-VS-KIRP CIMP |
1.65680000052681E-07 |
| Normal-VS-Unclassified PRCC |
5.213800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.116600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.571600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.746400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.925600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.212200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.851800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.78386252622931E-12 |
| Normal-vs-N1 |
1.19099999995598E-06 |
| Normal-vs-N2 |
2.124600E-03 |
| N0-vs-N1 |
2.215800E-01 |
| N0-vs-N2 |
7.900400E-01 |
| N1-vs-N2 |
7.797200E-01 |
|
|
